About this trial
The purpose of this graduate student research study is to compare the effects of low-load blood flow restriction training (LL-BFR) and heavy-load training (HLT) in high-volume rowers with mild low back pain or recurrent low back pain (LBP), aiming to determine whether LL-BFR offers a safer yet equally effective alternative to HLT for enhancing performance and reducing risk of re-injury.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Aged 13-20 years old
Currently active rower (training ≥3 days/week or 12 hours/week)
Mild LBP with a low reactivity (<3/10) or recurring LBP within the past 18 months that has affected attendance to team practices/races.
Able to complete a 2,000-meter rowing erg test
Disqualifiers
Have severe or acute back pain that limits basic movement or requires medical treatment
History of spinal surgery or structural spine conditions (scoliosis requiring bracing/surgery)
Peripheral vascular disease (PVD)
History of vascular surgery in arms or legs
Trial design
Parallel
Treatments tested in this trial
blood flow restriction
Other interventionThe SAGA blood flow restriction tourniquet system will be used for each training sessions for the rowers within the light load restriction group. The 4 inch-wide tourniquet will be applied to both upper thighs during the strength and endurance exercises. Tourniquet setting will be determined as the pressure needed to achieve 40-80% arterial occlusion to the extremity (as measured by the SAGA BFR unit). The SAGA units provides a consistent amount of pressure to the extremity throughout the ROM of the exercise. The settings will be determined at baseline and then recalibrated weekly.
Heavy load resistance training
Other interventionFor the resistance prescription, rowers will do strengthening exercises at 70-80% 1 RM. Exercises will be performed in series following 6 sets by 5 reps, with 120 seconds of rest between sets for each exercise.
Treatment groups
Trial outcomes
Primary outcomes
Hamstring and quadricep muscular fatigue assessment via Noraxon Electromyography
Sponsors and contacts
Click on the lead sponsor to view all of their trials.